Medite Cancer Diagnostics Stock Market Value
| MDIT Stock | USD 0.0001 0.00 0.00% |
| Symbol | Medite |
Medite Cancer 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medite Cancer's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medite Cancer.
| 11/02/2025 |
| 01/31/2026 |
If you would invest 0.00 in Medite Cancer on November 2, 2025 and sell it all today you would earn a total of 0.00 from holding Medite Cancer Diagnostics or generate 0.0% return on investment in Medite Cancer over 90 days. Medite Cancer Diagnostics, Inc. operates as a medical technology company More
Medite Cancer Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medite Cancer's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medite Cancer Diagnostics upside and downside potential and time the market with a certain degree of confidence.
Medite Cancer Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medite Cancer's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medite Cancer's standard deviation. In reality, there are many statistical measures that can use Medite Cancer historical prices to predict the future Medite Cancer's volatility.Medite Cancer Diagnostics Backtested Returns
We have found three technical indicators for Medite Cancer, which you can use to evaluate the volatility of the firm. The company secures a Beta (Market Risk) of 0.0, which conveys not very significant fluctuations relative to the market. the returns on MARKET and Medite Cancer are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Medite Cancer Diagnostics has perfect predictability. Overlapping area represents the amount of predictability between Medite Cancer time series from 2nd of November 2025 to 17th of December 2025 and 17th of December 2025 to 31st of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medite Cancer Diagnostics price movement. The serial correlation of 1.0 indicates that 100.0% of current Medite Cancer price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Medite Pink Sheet Analysis
When running Medite Cancer's price analysis, check to measure Medite Cancer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medite Cancer is operating at the current time. Most of Medite Cancer's value examination focuses on studying past and present price action to predict the probability of Medite Cancer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medite Cancer's price. Additionally, you may evaluate how the addition of Medite Cancer to your portfolios can decrease your overall portfolio volatility.